Domain Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Strasbourg
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Domain Therapeutics is a French immuno-oncology biotech developing small molecules targeting G-coupled protein receptors.
Investors:
we tracked 9 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 42M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Domain Therapeutics
Name | Criteria | |
---|---|---|
![]() |
CatalYm
70%
|
|
![]() |
Salvia BioElectronics
70%
|
|
![]() |
Synendos Therapeutics
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Eyevensys
70%
|
|
![]() |
Mestag Therapeutics
70%
|
|
![]() |
Emergence Therapeutics
70%
|
|
![]() |
PDC*line pharma
70%
|
|
![]() |
Atlantic Therapeutics
70%
|
|
![]() |
Sixfold Bioscience
70%
|
|